US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

71.56

-0.7881-1.09%

Post-market: 71.30-0.2619-0.37%16:10 EDT

Volume:212

Turnover:15.12K

Market Cap:715.69K

PE:- -

High:71.56

Open:71.36

Low:71.30

Close:72.35

52wk High:85.03

52wk Low:55.03

Shares:10.00K

Float Shares:10.00K

Volume Ratio:0.50

T/O Rate:2.12%

Dividend:2.08

Dividend Rate:2.90%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GSK’s New Sarcoma Trial Puts Fresh Spotlight on Its Oncology Pipeline

GSK-Backed DB-1324 Trial Marks Early Progress in Advanced Gastrointestinal Cancer

GSK Sets 2026 Results and Dividend Timetable, Plans Portfolio Growth Update

GSK Discloses Routine ADS Purchase by Non-Executive Director Hal Barron

GSK, Pan-Canadian Pharmaceutical Alliance Start Talks for Blenrep to Treat Blood Cancer

MT Newswires Live

GSK Executives Add Notional ADS Through Dividend Reinvestment Plan

GSK Nears Key Hepatitis B Milestone With Completion of B-Well 1 Phase 3 Trial

GSK Adds 1.7 Million Shares to Treasury in Ongoing Buyback Programme

GSK announces Japan’s MHLW expanded eligible population for Arexvy

GSK Wins Wider Japanese Approval for RSV Vaccine Arexvy in At-Risk Adults

Assessing 4DMedical’s Valuation After New GSK Contract And Rising Interest In Lung Imaging Technologies

Simply Wall St.

GSK’s B-Well 2 Hepatitis B Trial Reaches Completion, Setting the Stage for Key Data

GSK executives acquire shares under company reward plan

Assessing Sino Biopharmaceutical (SEHK:1177) Valuation After New GSK Partnership On Hepatitis B Drug Candidate

Simply Wall St.

Halozyme Q1 Beat Driven by Royalty Outperformance, Strong Demand, Morgan Stanley

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading

MT Newswires Live

GSK Reports Executive Notional ADS Acquisition Under Savings Plan

GSK Moves to Complete £2 Billion Share Buyback Programme

SBP GROUP (01177) Surges Over 4% in Afternoon Session Following Hepatitis B Treatment Collaboration Announcement

Sino Biopharmaceutical to Distribute GSK's Hepatitis B Drug in China

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/GSKH/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":71.5619,"timestamp":1787601600000,"preClose":72.35,"halted":0,"volume":212,"hourTrading":{"tag":"盘后","latestPrice":71.3,"preClose":71.5619,"latestTime":"16:10 EDT","volume":6,"amount":429.3714,"timestamp":1787602204676,"change":-0.2619,"changeRate":-0.00366,"amplitude":0},"delay":0,"changeRate":-0.01089288182446441,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Not Yet Opened","change":-0.7881,"latestTime":"08-24 16:00:00 EDT","open":71.36,"high":71.5619,"low":71.3,"amount":15118,"amplitude":0.00362,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":72.35,"nav":72.35762,"aum":723648.55762,"dividendRate":0.029015,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":71.3,"preClose":71.5619,"latestTime":"16:10 EDT","volume":6,"amount":429.3714,"timestamp":1787602204676,"change":-0.2619,"changeRate":-0.00366,"amplitude":0},"volumeRatio":0.503563,"impliedVol":0.1195,"impliedVolPercentile":0.2},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.503563,"shares":10001,"dividePrice":2.0764,"high":71.5619,"amplitude":0.00362,"preClose":72.35,"low":71.3,"week52Low":55.03,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":71.5619,"eps":0,"divideRate":0.029015,"volume":212,"delay":0,"ttmEps":0,"open":71.36,"prevYearClose":68.2031,"prevWeekClose":72.35,"prevMonthClose":71.6488,"prevQuarterClose":73.8574,"fiveDayClose":69.8844,"twentyDayClose":72.7499,"sixtyDayClose":72.3943},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637345094","title":"GSK’s New Sarcoma Trial Puts Fresh Spotlight on Its Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2637345094","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637345094?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:33","pubTimestamp":1779467595,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The Phase 1b/2 study “Phase 1b/2 Study Evaluating the Efficacy and Safe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-sarcoma-trial-puts-fresh-spotlight-on-its-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-sarcoma-trial-puts-fresh-spotlight-on-its-oncology-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK","BK4585","BK4532","GSK.UK","BK4007","GSKH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637043345","title":"GSK-Backed DB-1324 Trial Marks Early Progress in Advanced Gastrointestinal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637043345","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637043345?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:32","pubTimestamp":1779467577,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The study, titled “A Phase 1/2, Multicenter, Open-Label, First-in-Human...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-backed-db-1324-trial-marks-early-progress-in-advanced-gastrointestinal-cancer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-backed-db-1324-trial-marks-early-progress-in-advanced-gastrointestinal-cancer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z4B17.USD","BK4007","IE00B7SZL793.SGD","AEIS","BK4566","LU1829250122.USD","GSK.UK","GSKH","IE00B66KJ199.SGD","BK4585","LU0757428866.USD","BK4118","BK4097","DB","BK4552","BK4532","GSK","IE0031619046.USD","BK4588","LU2065732104.USD","BK4157","PRGS","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637058390","title":"GSK Sets 2026 Results and Dividend Timetable, Plans Portfolio Growth Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2637058390","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637058390?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:32","pubTimestamp":1779442343,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK plc has confirmed it will publish its Q2 2026 results on 28 July 2026 via the London Sto...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-sets-2026-results-and-dividend-timetable-plans-portfolio-growth-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-sets-2026-results-and-dividend-timetable-plans-portfolio-growth-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4532","BK4588","GSKH","LU1829250122.USD","GSK.UK","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636982596","title":"GSK Discloses Routine ADS Purchase by Non-Executive Director Hal Barron","url":"https://stock-news.laohu8.com/highlight/detail?id=2636982596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636982596?lang=en_us&edition=fundamental","pubTime":"2026-05-20 22:33","pubTimestamp":1779287591,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK disclosed that non-executive director Dr. Hal Barron acquired American Depositary ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-routine-ads-purchase-by-non-executive-director-hal-barron?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-routine-ads-purchase-by-non-executive-director-hal-barron?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4588","BK4532","BK4585","BK4007","LU1829250122.USD","GSKH","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636582326","title":"GSK, Pan-Canadian Pharmaceutical Alliance Start Talks for Blenrep to Treat Blood Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2636582326","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636582326?lang=en_us&edition=fundamental","pubTime":"2026-05-20 22:24","pubTimestamp":1779287047,"startTime":"0","endTime":"0","summary":"GSK  said Wednesday it has started negotiations with the pan-Canadian Pharmaceutical Alliance for the use of Blenrep to treat adults with relapsed or refractory multiple myeloma, a type of blood cancer.The talks cover the use of Blenrep plus bortezomib and dexamethasone, or combined with pomalidomide and dexamethasone, the company said.Price: 50.97, Change: -0.08, Percent Change: -0.16","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","GSK.UK","BK4007","BK4532","GSKH","LU1829250122.USD","BK4588","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636085769","title":"GSK Executives Add Notional ADS Through Dividend Reinvestment Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2636085769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636085769?lang=en_us&edition=fundamental","pubTime":"2026-05-19 22:32","pubTimestamp":1779201147,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK has disclosed a series of routine insider transactions involving senior leadership, i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-add-notional-ads-through-dividend-reinvestment-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-add-notional-ads-through-dividend-reinvestment-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4532","GSKH","GSK.UK","GSK","LU1829250122.USD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636112070","title":"GSK Nears Key Hepatitis B Milestone With Completion of B-Well 1 Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2636112070","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636112070?lang=en_us&edition=fundamental","pubTime":"2026-05-19 00:30","pubTimestamp":1779121816,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK’s latest hepatitis B update centers on its Phase 3 trial “Phase 3 M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-nears-key-hepatitis-b-milestone-with-completion-of-b-well-1-phase-3-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-nears-key-hepatitis-b-milestone-with-completion-of-b-well-1-phase-3-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","BK4588","BK4007","BK4585","GSK","GSKH","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636074420","title":"GSK Adds 1.7 Million Shares to Treasury in Ongoing Buyback Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2636074420","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636074420?lang=en_us&edition=fundamental","pubTime":"2026-05-18 22:25","pubTimestamp":1779114333,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK has repurchased 1,671,851 ordinary shares between 11 and 15 May 2026 under its ong...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-adds-1-7-million-shares-to-treasury-in-ongoing-buyback-programme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-adds-1-7-million-shares-to-treasury-in-ongoing-buyback-programme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4007","BK4585","GSK.UK","GSKH","LU1829250122.USD","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636271060","title":"GSK announces Japan’s MHLW expanded eligible population for Arexvy","url":"https://stock-news.laohu8.com/highlight/detail?id=2636271060","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636271060?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:50","pubTimestamp":1779101459,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced that Japan’s Ministry of Health, Labour and Welfare, MHLW, has expanded the eligible population for Arexvy, to include adults a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-announces-japans-mhlw-expanded-eligible-population-for-arexvy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-announces-japans-mhlw-expanded-eligible-population-for-arexvy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GSKH","GSK","GSK.UK","BK4007","LU1829250122.USD","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636042632","title":"GSK Wins Wider Japanese Approval for RSV Vaccine Arexvy in At-Risk Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2636042632","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636042632?lang=en_us&edition=fundamental","pubTime":"2026-05-18 14:12","pubTimestamp":1779084756,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has secured expanded approval in Japan for its RSV vaccine Arexvy, which can now...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-wins-wider-japanese-approval-for-rsv-vaccine-arexvy-in-at-risk-adults?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-wins-wider-japanese-approval-for-rsv-vaccine-arexvy-in-at-risk-adults?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4585","BK4532","BK4588","GSK.UK","GSK","BK4007","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635065547","title":"Assessing 4DMedical’s Valuation After New GSK Contract And Rising Interest In Lung Imaging Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2635065547","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635065547?lang=en_us&edition=fundamental","pubTime":"2026-05-16 19:40","pubTimestamp":1778931634,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) is back in focus after securing a one year contract with GlaxoSmithKline to supply quantitative lung imaging analytics for pulmonary drug development, while its respiratory imaging technologies draw heightened investor attention.\nSee our latest analysis for 4DMedical.\nThe GSK contract has arrived at a time when momentum around the stock is shifting again, with the share price up 8.88% in the last day and 29.91% over the week, but down 34.12% over 30 days, while very large...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-new-gsk-contract-and-ri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-new-gsk-contract-and-ri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4532","BK4007","GSK","LU1829250122.USD","4DX.AU","BK4585","BK4588","BK7094","GSK.UK","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635039609","title":"GSK’s B-Well 2 Hepatitis B Trial Reaches Completion, Setting the Stage for Key Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2635039609","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635039609?lang=en_us&edition=fundamental","pubTime":"2026-05-16 00:30","pubTimestamp":1778862610,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The Phase 3 B-Well 2 trial from GlaxoSmithKline tests bepirovirsen in p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-b-well-2-hepatitis-b-trial-reaches-completion-setting-the-stage-for-key-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-b-well-2-hepatitis-b-trial-reaches-completion-setting-the-stage-for-key-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4585","SSI","BK4532","BK4007","GSK","BK4588","GSKH","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635746355","title":"GSK executives acquire shares under company reward plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2635746355","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635746355?lang=en_us&edition=fundamental","pubTime":"2026-05-14 22:33","pubTimestamp":1778769185,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has disclosed a series of routine share dealings by senior executives under its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-company-reward-plan-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-company-reward-plan-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4532","GSKH","LU1829250122.USD","BK4585","BK4007","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635473240","title":"Assessing Sino Biopharmaceutical (SEHK:1177) Valuation After New GSK Partnership On Hepatitis B Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635473240","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635473240?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:49","pubTimestamp":1778611767,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (SEHK:1177) has drawn fresh investor attention after subsidiary Chia Tai Tianqing agreed an exclusive partnership with GSK to commercialise bepirovirsen for chronic hepatitis B in mainland China.\nSee our latest analysis for Sino Biopharmaceutical.\nThe partnership news lands after a mixed price run, with the stock up 2.12% on a 1 day share price return and 6.25% over 7 days, yet down 15.37% over 90 days. The 1 year total shareholder return of 52.60% contrasts with weaker...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/assessing-sino-biopharmaceutical-sehk1177-valuation-after-ne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/assessing-sino-biopharmaceutical-sehk1177-valuation-after-ne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000165453.HKD","01177","GSK.UK","BK1515","BK4532","BK4588","IE00BZ08YT58.USD","LU1829250122.USD","DCF","BK1589","BK1191","BK1521","IE00BZ08YR35.GBP","BK4585","BK4007","IE00BZ08YS42.EUR","GSKH","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634245198","title":"Halozyme Q1 Beat Driven by Royalty Outperformance, Strong Demand, Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2634245198","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634245198?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:54","pubTimestamp":1778601257,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics (HALO) posted stronger-than-expected Q1 results, with revenue beating consensus on continued royalty-driven outperformance and sustained momentum across its Enhanze portfolio, Mo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2271345857.HKD","VRTX","LU2462157665.USD","LU0158827781.USD","LU1244550221.USD","LU0390134368.USD","LU1548497426.USD","LU0912757837.SGD","LU2357305700.SGD","LU2362541513.USD","GSK","BK4139","LU2089283258.USD","ORKA","LU1093756168.USD","LU0289739699.SGD","LU0058720904.USD","LU1791710400.SGD","IE00B4R5TH58.HKD","BK4516","BK4532","LU1162221912.USD","LU2028103732.USD","IE0009355771.USD","LU0314104364.USD","LU2362540622.SGD","LU1989772923.USD","LU0053671581.USD","LU0158827948.USD","IE00BJT1NW94.SGD","LU2456880835.USD","BK4567","SG9999001176.USD","BK4127","LU1035775433.USD","LU0109394709.USD","LU2236285917.USD","BK4007","LU0106261372.USD","LU1791710582.SGD","LU0823416689.USD","LU1064131342.USD","LU1093756325.SGD","LU1720051108.HKD","HALO","LU2347655156.SGD","GSK.UK","LU1988902786.USD","LU0795875169.SGD","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634436482","title":"European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634436482","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634436482?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:14","pubTimestamp":1778598868,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down significantly late Tuesday morning, dropping 1.05% to 1,814.06 on the S&P Europe Select ADR Index.From continental Europe, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","EPV","BK4007","BK4075","GSK","BK4020","NOK","BK4139","LU0162691827.USD","LU0072461881.USD","BK4141","CRTO","LU0006061336.USD","BK4107","BTI","LYG","CUK","VOD","BK4132","MREO","BK4588","GSK.UK","SQNS","SLN","OPRA","IEUR","LNOK","IE00BMPRXN33.USD","BK4117","LU1829250122.USD","IE00BMPRXR70.SGD","BK4077","BK4585","TRVG","BTI.AU","BK4023","LU2543165471.USD","MTLS","BK4546","DBVT","CLLS","BK4142","BK4207","AKTX","BK7062","GSKH","AFG","BK4505","IE00BFMHRM44.USD","BK4521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634807292","title":"GSK Reports Executive Notional ADS Acquisition Under Savings Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2634807292","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634807292?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:33","pubTimestamp":1778510003,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK disclosed that Maya Martinez-Davis, its President for the US, acquired a small number of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-reports-executive-notional-ads-acquisition-under-savings-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-reports-executive-notional-ads-acquisition-under-savings-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","GSK","BK4532","BK4585","BK4588","GSKH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634435477","title":"GSK Moves to Complete £2 Billion Share Buyback Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2634435477","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634435477?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:09","pubTimestamp":1778479782,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has launched the fifth and final tranche of its previously announced £2 billion sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-moves-to-complete-2-billion-share-buyback-programme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-moves-to-complete-2-billion-share-buyback-programme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","LU1829250122.USD","GSKH","BK4585","BK4588","BK4532","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118145858","title":"SBP GROUP (01177) Surges Over 4% in Afternoon Session Following Hepatitis B Treatment Collaboration Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1118145858","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118145858?lang=en_us&edition=fundamental","pubTime":"2026-05-11 13:42","pubTimestamp":1778478148,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) saw its shares rise more than 4% in the afternoon trading session. At the time of writing, the stock was up 4.05% to HK$5.65, with a turnover of HK$278 million. The catalyst for the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","VXUS","BK1515","GSKH","01177","BK4007","GSK.UK","BK1521","BK1191","BK1589","HK0000165453.HKD","BK4532","IE00BZ08YR35.GBP","GSK","IE00BZ08YS42.EUR","BK4585","BK4588","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634713684","title":"Sino Biopharmaceutical to Distribute GSK's Hepatitis B Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2634713684","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634713684?lang=en_us&edition=fundamental","pubTime":"2026-05-11 12:40","pubTimestamp":1778474442,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  secured a supply deal for GlaxoSmithKline's hepatitis B drug, bepirovirsen, for China, according to a Monday filing with the Hong Kong bourse.The firm's Chia Tai Tianqing Pharmaceutical Group entered into an exclusive strategic collaboration with GSK to cover the importation and distribution of bepirovirsen in mainland China for an initial term of 5.5 years at launch.Sino Biopharmaceutical's shares were up nearly 2% in midday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","BK1191","GSK","IE00BZ08YR35.GBP","BK1589","BK4585","IE00BZ08YS42.EUR","BK4532","BK4007","IE00BZ08YT58.USD","LU1829250122.USD","BK4588","HK0000165453.HKD","01177","BK1515","BK1521","GSKH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}